Keywords: |
mortality; drug efficacy; nonhuman; united states; morbidity; editorial; influenza vaccination; food and drug administration; health service; government; public health service; health care personnel; world health organization; infection prevention; humoral immunity; influenza vaccine; drug sensitivity; virus strain; viral matrix proteins; infection sensitivity; oseltamivir; sialidase inhibitor; influenza virus a; influenza virus b; influenza, human; drug resistance, viral; china; antiviral agents; influenza a virus, h1n1 subtype; virus isolation; zanamivir; amantadine; russian federation; avian influenza; severe acute respiratory syndrome; adamantane; protein m2; rimantadine; influenza a; influenza a virus; influenza a virus, h3n2 subtype
|